The research of the antibacterial activity of yeast Saccharomyces cerevisiae var. boulardii Az-12

2019

Full text Open access: Gold Metadata (CSL-JSON)
DOI 10.32523/2616-7034-2019-128-3-80-89
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

The problem of treatment and prevention of acute intestinal infections is urgent in all countries without exception. The strain Saccharomyces cerevisiae Az-12, isolated from the juice of pomegranate, grown in the Turkestan region, shows the features of the probiotic culture Saccharomyces cerevisiae var. boulardii. Saccharomyces cerevisiae Az-12 antago nistic abilities were studied with the following conditionally pathogenic or pathogenic bacteria: Escherichia coli, Enterococcus faecalis, Pseudomonas aeruginosa, Salmonella typhimurium, Staphylococcus aureus as the most common bacteria associated with diarrhea diseases. Saccharomyces cerevisiae Az-12 has a distinct inhibitory relationship to Staphylococcus aureus and Escherichia coli. It has been proven that probiotic activity of Saccharomyces cerevisiae Az-12 against human pathogens is due to a decrease in bacterial growth and due to the adherence of bacteria to the walls of yeast cells. Probiotic yeast cultures Saccharomyces cerevisiae var. boulardii Az-12 can be used as a preventive and therapeutic agent for the treatment of various diarrheal diseases